Public Health On Call

About this episode: Amidst an ongoing outbreak of a deadly clade of mpox in the Democratic Republic of the Congo, the Johns Hopkins Center for Communication Programs has been part of the response team. Working with local partners, CCP has developed community outreach and strategic communications campaigns to help protect people, reduce transmission, and get the outbreak under control. When USAID f...

About this episode: As a follow up to our recent episode titled The Potential Impacts of Cuts To Medicaid, we're partnering with our friends at the Tradeoffs podcast. Guest hosts Dan Gorenstein and Ryan Levi, longtime health reporters, take a deeper look at why many Republicans believe a smaller Medicaid program would be a better Medicaid, what proposed cuts might look like, and the challenges Rep...

About this episode: Medicaid helps make health care accessible to millions of adults and children in the U.S. In this episode: a look at the potential impacts of federal budget cuts on states, hospitals, physicians, and the beneficiaries themselves. Guests: Dr. Gerard Anderson is an expert in health policy and a professor in Health Policy and Management and International Health at the Johns Hopkin...

About this episode: According to the WHO, there are an estimated 300,000 drowning deaths worldwide each year and a quarter of them are children under 5. But because the risk factors are so diverse—from backyard swimming pools to monsoons to the fishing industry—preventing drowning deaths requires viewing the problem through a public health lens and investing in a multitude of approaches, many of w...

About this episode: Ketamine is in the news again. In this episode: a conversation about the differences between ketamine and esketamine—an FDA-approved medicine for treatment-resistant depression—why we're hearing so much about ketamine right now, and the importance of administering esketamine in a clinical setting as part of a broader comprehensive mental health strategy. Guest: Dr. Paul Kim is...

About this episode: For some people with a high risk of ovarian cancer, a standard approach has been full removal of the reproductive organs. But new research points to a far less invasive procedure called a salpingectomy, or removal of the fallopian tubes, as a potential "game changer" in ovarian cancer. In this episode: understanding high grade serous carcinoma—the most common type of ovarian ca...

About this episode: A new report on misinformation and disinformation from the National Academies of Science, Engineering, and Medicine is helping to define what misinformation is and how it starts and how to combat it. In this episode: a conversation about the findings, and how to get away from misinformation as a name-calling contest. Guest: Vish Viswanath  is the Lee Kum Kee Professor of Health...

About this episode: Questions about vaccines and autism have been around for a while despite multiple scientific studies that do not show a connection. In this episode: where the concerns started, the science behind why experts have concluded there is no link, and why these questions still persist. Guest: Dan Salmon is the director of the Johns Hopkins Institute For Vaccine Safety . Host: Dr. Josh...

About this episode: In the early days of the COVID-19 pandemic when there were no vaccines or treatments, convalescent plasma—antibody-containing blood from people who recovered from COVID—saved countless lives through Emergency Use Authorization. In this episode: special guest host Thomas Locke of MMI Monthly: From Bench To Breakthrough discusses the evolution of CCP therapy, from emergency use d...

About this episode: John Green is a New York Times bestselling author and YouTuber known for writing books like The Fault In Our Stars . His latest book is about tuberculosis. In this episode: A conversation with John Green about why he chose to write about TB, the current state of public health and its challenges, and how the disease and its prevalance reflects so much back on us in terms of who...

About this episode: In another episode in our series on vaccines: the different types of vaccines and how they work, and the logic and timing of the childhood vaccination schedule. Also: A conversation about measles vaccinations for children younger than 1 year. Guest: Dr. Bill Moss is the executive director of the International Vaccine Access Center at the Johns Hopkins Bloomberg School of Public...

About this episode: At the bottom of the world's oceans lie valuable deposits of cobalt, manganese, and other minerals. In today's episode: a deep dive on deep-sea mining, the environmental impacts, and how the world might approach regulating mining in areas that technically belong to everyone. Guests: Andrew Thaler is a deep-sea ecologist, conservation technologist, and an ocean educator. Host: L...

About this episode: A measles outbreak that started in west Texas has sickened more than 150 people and killed a child. In today's episode: the scope of the outbreak and how it's spreading, the challenges of trying to control it, and claims about treatments including vitamin A, steroids, and antibiotics. Guest: Dr. Bill Moss is the executive director of the International Vaccine Access Center at t...

About this episode: A large-scale, multi-country autism study involving more than 175,000 individuals is hoping to find interplay between genes and the environment that may influence autism diagnosis and symptoms. But proposed NIH funding cuts could imperil the study's future. In this episode: A look at an NIH-funded study that hopes to improve the quality of life for people with autism and their...

About this episode: Research shows that seed oils, like sunflower and sesame, can contribute to better health. So why are wellness influencers talking about a group called "the hateful eight," which include non-seed oils like soybean and canola? In this episode: a breakdown of what seed oils are (and aren't), misconceptions around inflammation and omega 6's, and how processed foods play into the c...

About this episode: Neglected diseases like mycetoma, Chagas disease, and leishmaniasis impact more than a billion people worldwide every year and kill hundreds of thousands. In this episode: Why these illnesses don't get widespread attention or the resources needed for prevention, diagnosis and treatment, and how in a shifting global funding landscape, cross-sector collaboration is key to allevia...

About this episode: In today's episode: defining sex, gender, and gender identity, and why the concepts of gender and gender identity help with the understanding of and response to health challenges. Guests: Sari Reisner is an epidemiologist at the University of Michigan. Host: Dr. Josh Sharfstein is vice dean for public health practice and community engagement at the Johns Hopkins Bloomberg Schoo...

About this episode: The abrupt halt of USAID funded programs around the world has caused confusion and chaos, and the consequences are likely to have a long tail. In today's episode: Joe Amon, an expert in global aid and human rights, discusses some of the direct and indirect impacts of disengaging from this work. Guests: Joe Amon is the director of the Johns Hopkins Center for Public Health and H...

About this episode: Firearm purchaser licensing laws that have provisions such as enhanced background checks and in-person applications curb homicides and suicides, they're bipartisan, and a majority of Americans—including gun owners—support them. In today's episode: A look at a new report with recommendations for building a safer gun-buying process and why now is the time to implement these solut...

About this episode: Although cannabis is legal in nearly half of all U.S. states, policy is complicated. There's federal law, which prohibits the sale of THC-containing cannabis but not hemp. There's state law, which is an even more complex patchwork. In this episode: A new report looks at how this hazy landscape is impacting public health policy and equity. Guests: Dr. Yasmin Hurd is a neuroscien...

About this episode: In today's episode: A discussion with Dr. Lisa Cooper, the director of the Johns Hopkins Center for Health Equity, about opposition to the terms "diversity," "equity," and "inclusion." Guests: Dr. Lisa Cooper is a public health physician, a Bloomberg Distinguished Professor at Johns Hopkins and a winner of a MacArthur genius grant for her work to understand and reduce health di...

About this episode: Since the overturning of Roe v. Wade, some states have imposed severe restrictions on access to abortion. In this episode: New research on what's happened to infant death and birth rates in these states. Guests: Suzanne Bell is a Johns Hopkins demographer the department of Population, Family and Reproductive Health . Alison Gemmill is a Johns Hopkins demographer and perinatal e...

About this episode: During the pandemic, CDC recommendations about masking and other issues were the source of controversy. Some have asked whether the agency can better communicate the basis of its recommendations — and even seek public input along the way—to increase public understanding and acceptance.  In today's episode, Johns Hopkins cardiologist Dr. Joseph Marine and Dr. Peter Lurie of the...

About this episode: There's a lot of flu out there right now, but just how bad is it and by what measures is it "bad"? In today's episode: How this year's flu season stacks up against years past, some factors that could be driving such high rates and severe disease, and how bird flu is further complicating things. Also: It's not too late to get a flu shot! Guests: Dr. Erica Prochaska is a pediatri...

About this episode: The FDA is responsible for labeling on food packaging, such as the ubiquitous black and white nutrition label. But consumers could soon see new labels on foods offering more information about nutrition in key areas like sodium, sugar, and saturated fat. In today's episode: the FDA's proposed changes for food labeling and new standards for using the term "healthy" in everything...